Navigation Links
Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2011
Date:8/8/2011

share, compared to $836,000, or $0.06 per diluted share, in the prior year period. For the second quarter of 2011, weighted average diluted shares outstanding were 17.5 million.

As of June 30, 2011, the Company had $77.3 million in cash and cash equivalents and investments.

First Half 2011 Financial ResultsDuring the first half of 2011, revenue from healthcare services increased 17.0% to $53.7 million from $45.9 million in the prior year period, reflecting growing inpatient and outpatient volume across the United Family Healthcare network. Outpatient services contributed 60% of revenue and inpatient services contributed 40% of revenue in the first half of 2011 compared to 59% and 41%, respectively, in the year ago period. By service line, surgical services contributed 18.0%, OB/GYN contributed 14.5%, pediatrics contributed 8.0%, ancillary services contributed 33.0% and other services contributed 26.5% of revenue.

Operating expenses for the first half of 2011 increased 21.6% to $50.6 million from $41.6 million in the prior year period. Development, pre-opening and start up expenses rose to $2.0 million from $801,000 in the prior year period primarily as a result of expenses related to the Company's Beijing, Pudong and Tianjin projects. Operating expenses also included certain non-cash expenses including $1.7 million of non-cash stock compensation expense and increased corporate cost allocations of approximately $650,000 due to the change in business organization when compared to the prior year. Income from operations was $3.1 million compared to income from operations of $3.0 million in the prior year period. Adjusted EBITDA was approximately $8.4 million compared to $6.9 million in the prior year period.

Provision for taxes was $2.1 million compared to $1.8 million in the prior year period. Net income was $1.7 million, or $0.11 per diluted share, compared to net income of $1.4 million, or $0.09 per diluted share, in th
'/>"/>

SOURCE Chindex International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Chindex International, Inc. to Report Financial Results for the Second Quarter and First Half of 2011
2. Naviscan Announces Partnership With Chindex Medical Limited for Mainland China, Hong Kong and Macau
3. Chindex International, Inc. Reports First Quarter 2011 Financial Results
4. Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010
5. Chindex International to Report Financial Results for the Three and Nine-Month Periods Ended December 31, 2010
6. Chindex and Fosun Pharma Form Joint Venture
7. Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2011 Financial Results
8. Fosun Pharma Acquires $14 Million of Chindex Stock
9. Chindex International to Report First Quarter 2011 Financial Results
10. Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results
11. Chindex International to Report Third Quarter Fiscal Year 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 31, 2014  Zebra Imaging, Inc., the world,s ... today a strategic partnership with the Zygote Media ... anatomy and biomedical models for animation and visual ... markets.  Zygote maintains the world,s most comprehensive library ... has pioneered development of high-end solid 3D anatomy ...
(Date:10/31/2014)...  Australian biopharmaceutical company Specialised Therapeutics Australia (STA) is ... in combination with gemcitabine, will be reimbursed via the ... cancer from 1 November. In ... th most common cause of cancer mortality. Pancreatic ... the lowest 5-year survival of all common cancers at ...
(Date:10/31/2014)... 31, 2014 Oramed Pharmaceuticals ... company focused on the development of oral drug ... a conference call to discuss the clinical results ... the company,s proprietary oral insulin capsules, to treat ... at 10:00 a.m. Eastern time. Shareholders ...
Breaking Medicine Technology:Zebra Imaging and Zygote Media Partner to Bring 3D Visualization to the Medical Community 2Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 2Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 3Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 4Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 5Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 6Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 7Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 8Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3
... SAN DIEGO, Nov. 28, 2011 OncoSec Medical ... advanced-stage OMS ElectroOncology therapies to treat skin cancer ... Punit Dhillon, President and CEO, will be presenting ... Conference in New York City. (Logo: ...
... 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP ... and biotechnology research and development outsourcing company, today announced ... investor conferences in December 2011: Ms. Lan ... ShangPharma, will present at the following conferences: ...
Cached Medicine Technology:OncoSec to Present at 15th Annual Biotech and Specialty Pharmaceuticals Conference 2ShangPharma to Attend Two Upcoming Investor Conferences 2
(Date:10/31/2014)... October 31, 2014 Energy Textiles has ... The new gear is now available online, and Energy ... benefits of Celliant infrared-active athletic gear over compression gear. ... another contract has been signed for Under Armour to ... the next eight years. In light of this decision, ...
(Date:10/31/2014)... News) -- Obesity increases the risk of certain types ... two new U.S. studies show. One study of ... obese increased the risk for estrogen receptor-negative and progesterone ... this for a long time for white women, but ... study author Esther John, a senior research scientist at ...
(Date:10/31/2014)... older Americans say that either they or a family ... to the latest issue of The Gerontological Society of ... PP&AR ), which goes on to show that Americans ... honor patients, end-of-life health care wishes. , This ... Options ," features 12 articles that present new ways ...
(Date:10/31/2014)... Colorado (PRWEB) October 31, 2014 The ... that this workout program was developed by Dan Long, ... become well-known as a fitness professional and life coach. ... fat and having toned muscles is not impossible , ... based on suspension training. Suspension training promises efficiency when ...
(Date:10/31/2014)... RESEARCH UK scientists have found a drug combination that ... - paving the way for new treatments, according to ... Research Institute (NCRI) Cancer Conference in Liverpool next week*. ... initiate a chain of events culminating in self destruction. ... and become immortal. This means that cells grow out ...
Breaking Medicine News(10 mins):Health News:Compression Gear--Is There a Better Alternative? 2Health News:Compression Gear--Is There a Better Alternative? 3Health News:Compression Gear--Is There a Better Alternative? 4Health News:Study Confirms Obesity-Breast Cancer Link for Blacks, Hispanics 2Health News:Advance directives can benefit patients, families, and health care system 2Health News:Suspension Revolution Review Reveals Dan Long's New Suspension Workout Plan 2Health News:Scientists trigger self-destruct switch in lung cancer cells 2
... with hepatitis C are fine for patients with the ... News) -- Every year, hundreds of kidneys are thrown ... but they could help many hepatitis C-infected patients waiting ... fact, since 1995, more than 3,500 kidneys infected with ...
... journal Cell , a Cell Press publication, reveal a new ... and quickly in the tumors of cancer patients undergoing therapy. First ... enter a drug-tolerant state. But there,s some potentially very good news ... or block cancer,s drug resistance. "The problem with cancer ...
... Finding shows drug resistance can be lost, treatment can work ... identified a mechanism by which certain tumor cells that become ... , The discovery may lead to new ways to combat ... new study, published online April 1 in the journal ...
... Although new developments in the management of spinal cord injuries ... condition is more likely to involve a multidisciplinary approach, drawing ... published in the April 2010 issue of the Journal ... ). Each year, approximately 12,000 men ...
... ... in the hands of college students and challenging them to do good in their community in ... Your Community? , ... April 1, 2010 -- 5-Hour Energy® is traveling to campuses across the nation to put its ...
... ... real-time a key differentiator , ... Marlborough, MA (PRWEB) April 1, 2010 -- LogMatrix, a provider of log management, threat management ... currently using the LogMatrix LogCenter solution to capture and report on over 2 billion events ...
Cached Medicine News:Health News:Hundreds of Donor Kidneys Tossed Away Each Year 2Health News:Hundreds of Donor Kidneys Tossed Away Each Year 3Health News:Tumor cells seek temporary shelter from cancer drugs 2Health News:Tumor cells seek temporary shelter from cancer drugs 3Health News:Study Suggests How Some Cancers Resist Treatment 2Health News:Study Suggests How Some Cancers Resist Treatment 3Health News:Next decade offers promise for treatment of spinal cord injuries 2Health News:5-Hour Energy Challenges College Students To Make a Difference In Their Community 2Health News:LogMatrix Log Management Solution Easily Supports Customer's Extreme Scalability and Data Retrieval Requirements 2
This ENDOLOOP suture has a suture type - 0 ETHIBOND EXCE and a 1.5 inch diameter....
... ENDOLOOP consists of 18'' long ligature inserted into a ... end and scored on the other. The suture protrudes ... ligature loop with a knot which becomes secure after ... suture is fastened to the scored end of the ...
... inserted into a plastic tube. The plastic tube is ... The suture protrudes from the narrow end and is ... becomes secure after the device is activated. The opposite ... end of the plastic tube. The scored end acts ...
... inserted into a plastic tube. The plastic tube is ... The suture protrudes from the narrow end and is ... becomes secure after the device is activated. The opposite ... end of the plastic tube. The scored end acts ...
Medicine Products: